Apr 27, 2022
97:89
For every 89 shares held, investors received 97.
The split itself did not change the total investment value.
Egetis Therapeutics AB (GETTEX:P0F) operates in the Pharmaceuticals: major industry.
Egetis Therapeutics AB company overviewEgetis Therapeutics AB's most recent stock split was on April 27, 2022. It was a 97-for-89 forward split, so shareholders received 97 shares for every 89 they held.
Egetis Therapeutics AB (GETTEX:P0F) has split its stock 3 times: a 44-for-43 split on May 26, 2011, a 71-for-70 split on April 15, 2014, and a 97-for-89 split on April 27, 2022.
Egetis Therapeutics AB has split its stock 3 times. This history records 3 forward splits between May 26, 2011 and April 27, 2022.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Egetis Therapeutics AB's 97-for-89 split on April 27, 2022, every 89 shares became 97 shares.
Egetis Therapeutics AB has not announced a new split in our records. Its most recent split was on April 27, 2022, 4 years ago. Companies announce splits in advance, and any new GETTEX:P0F split will appear on this page.
Already premium?